Cite

HARVARD Citation

    Sentana-Lledo, D. et al. (2022). Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer. Lung cancer. pp. 124-126. [Online]. 
  
Back to record